NASDAQ: MOBIMobia Medical Inc Stock
$11.75
Updated May 8, 2026
MOBI Price
$11.75
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$10.19
52 Week High
$14.00
P/E
-0.21x
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$32.04M
Earnings
-$46.50M
Gross Margin
81.1%
Operating Margin
-142.08%
Profit Margin
-145.1%
Debt to Equity
-0.13
Operating Cash Flow
-$46M
Beta
N/A
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MOBI Overview
Mobia Medical, Inc. operates as a commercial-stage medical device company. It engages in developing solutions for stroke recovery survivors with motor impairments. The company was founded by Lawrence James Cauller, Navzer Engineer, Thomas Jordan Curnes II, and William Michael Rosellini on March 5, 2007 and is headquartered in Austin, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MOBI's potential to beat the market
- MOBI doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
MOBI
RankedUnranked of 95
RankedUnranked of 95
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.50 | A | |
| $26.93 | A | |
| $25.65 | A |
Be the first to know about important MOBI news, forecast changes, insider trades & much more!
MOBI News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MOBI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MOBI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MOBI is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
MOBI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more MOBI due diligence checks available for Premium users.
Valuation
MOBI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.21x
Industry
21.62x
Market
23.73x
MOBI's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
MOBI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MOBI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$48.1M
Liabilities
$19.1M
Debt to equity
-0.13
MOBI's short-term assets ($46.36M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MOBI's short-term assets ($46.36M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MOBI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MOBI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
MOBI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
Mobia Medical Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.